Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum
Ulrike Grienke(Universität Innsbruck), Judith M. Rollinger(University of Vienna), Hermann Stuppner(Universität Innsbruck), De‐an Guo(Chinese Academy of Sciences), Shuhong Guan(Soochow University), Markus Binder(Medical University of Vienna), Taras Afonyushkin(CeMM Research Center for Molecular Medicine), Judit Mihaly‐Bison(Medical University of Vienna), Gerhard Wolber(Research Institute for Pharmacy and Biochemistry (Czechia)), Daniela Schuster(Trinity College Dublin), Valery N. Bochkov(Medical University of Vienna), Chun‐Ru Cheng
Cited by 72
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Energy/Temperature Diagram and Compression Behavior of the Polymorphs of d-Mannitol
|Journal of Pharmaceutical Sciences|2000|363